Publication: JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study
JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study
Date
Date
Date
Citations
Fischer, M., Olbrich, P., Hadjadj, J., Aumann, V., Bakhtiar, S., Barlogis, V., von Bismarck, P., Bloomfield, M., Booth, C., Buddingh, E. P., Cagdas, D., Castelle, M., Chan, A. Y., Chandrakasan, S., Chetty, K., Cougoul, P., Crickx, E., Dara, J., Deyà-Martínez, A., … et al. (2024). JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study. Journal of Allergy and Clinical Immunology, 153, 275-286.e18. https://doi.org/10.1016/j.jaci.2023.10.018
Abstract
Abstract
Abstract
Background: Inborn errors of immunity (IEI) with dysregulated JAK/STAT signaling present with variable manifestations of immune dysregulation and infections. Hematopoietic stem cell transplantation (HSCT) is potentially curative, but initially reported outcomes were poor. JAK inhibitors (JAKi) offer a targeted treatment option that may be an alternative or bridge to HSCT. However, data on their current use, treatment efficacy and adverse events are limited.
Objective: We evaluated the current off-label JAKi treatment experience for J
Metrics
Views
Additional indexing
Creators (Authors)
Journal/Series Title
Journal/Series Title
Journal/Series Title
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Keywords
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Metrics
Views
Citations
Fischer, M., Olbrich, P., Hadjadj, J., Aumann, V., Bakhtiar, S., Barlogis, V., von Bismarck, P., Bloomfield, M., Booth, C., Buddingh, E. P., Cagdas, D., Castelle, M., Chan, A. Y., Chandrakasan, S., Chetty, K., Cougoul, P., Crickx, E., Dara, J., Deyà-Martínez, A., … et al. (2024). JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study. Journal of Allergy and Clinical Immunology, 153, 275-286.e18. https://doi.org/10.1016/j.jaci.2023.10.018